IPSUM Cardiovascular sites:
Enhancing your cardiovascular program with knowledge and in sight
IPSUM has the experience, operational capability and the resources necessary to successfully support protocol development and manage complicated trial execution.
Cardiovascular research and development is extremely vital when considering that heart disease is the number one cause of mortality worldwide. Cardiovascular drug and device development are among the most complicated therapeutic areas to navigate.
IPSUM can help design a regulatory strategy, meet with health authorities, and achieve agreement on essential study design that will lead to a successful study outcome.
Advanced clinical services for cardiovascular disease
Including stroke, heart attack and heart failure
We help your cardiovascular program accomplish:
- Reduced timelines for drug or device development
- Greater cardiac safety services that augment your treatment’s potential
- Earlier site start-up and patient recruitment
- Enriched predictability of outcomes through ingenious trial designs
Involve our Cardiovascular Sites of Excellence
Providing local infrastructure, scientific knowledge and technological innovation for your cardiovascular studies
We identify cardiovascular investigators from our broad database. We run studies at our own sites and also collaborate with experienced, trained, and inspired partner sites. After being selected, we maintain smooth contact with study sites, guaranteeing a timely start, efficient recruitment, and strong patient retention for trials. We work with sponsors to recognize study specific risks and take appropriate measures early on.
Once the study is deployed, the program is monitored based on risk with the help of skilled CRA’s. Project managers and medical monitors also deliver supervision and efficiently pilot the program execution.
- Metabolic Disease/Syndrome
- Atrial fibrillation
- Coronary artery disease
- Heart failure
- High-risk CVD
- Ischemic heart disease
- Acute coronary syndrome
- Aortic aneurysm
- Arterial hypertension
- Atherosclerotic disease
- Peripheral artery disease
- Venous thromboembolism